Mark A Glickman Therapeutics Md, Inc. (TXMD) insider trading activity

TXMD Quotes by TradingView

Mark A Glickman is Co-Chief Executive Officer of TherapeuticsMD, Inc.. Currently has a direct ownership of 1,294 shares of TXMD, which is worth approximately $1,436. The most recent transaction as insider was on Dec 06, 2022, when has been sold 440 shares (Common Stock) at a price of $4.92 per share, resulting in proceeds of $2,164. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.29K
0% 3M change
0% 12M change
Total Value Held $1,436

Mark A Glickman Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 06 2022
SELL
Open market or private sale
$2,164 $4.92 p/Share
440 Reduced 25.37%
1,294 Common Stock
Dec 06 2022
BUY
Exercise of conversion of derivative security
-
1,734 Added 50.0%
1,734 Common Stock

Also insider at

NRBO
NeuroBo Pharmaceuticals, Inc. Healthcare
Director
MAG

Mark A Glickman

Co-Chief Executive Officer
Boca Raton, FL

Track Institutional and Insider Activities on TXMD

Follow TherapeuticsMD, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TXMD shares.

Notify only if

Insider Trading

Get notified when an Therapeutics Md, Inc. insider buys or sells TXMD shares.

Notify only if

News

Receive news related to TherapeuticsMD, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TXMD